Jaren Madden
Investor Relations Kontakt bei SCHRÖDINGER, INC.
Aktive Positionen von Jaren Madden
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SCHRÖDINGER, INC. | Investor Relations Kontakt | 01.11.2020 | - |
| Public Communications Contact | 01.11.2020 | - |
Karriereverlauf von Jaren Madden
Ehemalige bekannte Positionen von Jaren Madden
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2017 | 01.07.2018 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.01.2010 | 01.01.2017 |
| Public Communications Contact | 01.01.2010 | 01.01.2017 | |
| GAMIDA CELL LTD. | Investor Relations Kontakt | 01.07.2018 | - |
| Public Communications Contact | 01.07.2018 | - |
Ausbildung von Jaren Madden
| University of Connecticut | Graduate Degree |
| Boston University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
| Israel | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
- Börse
- Insiders
- Jaren Madden
- Erfahrung
